Outsmarting Cancer to Deliver More Cures
CARGO is developing next-generation transformational CAR T-cell therapies with the mission of outsmarting cancer to deliver more cures for patients.
News
CARGO Therapeutics Announces Pricing of Initial Public Offering
Read More ⟶-
CARGO Therapeutics Announces Appointment of Ginna Laport, MD, as Chief Medical Officer
Read More ⟶: CARGO Therapeutics Announces Appointment of Ginna Laport, MD, as Chief Medical Officer -
CARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific Officer
Read More ⟶: CARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific Officer
Life at CARGO
CARGO Therapeutics is Now Hiring. Join us to make a difference.
Open Positions ⟶
